Reply to: “Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'”

Reply to: “Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'”

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Hepatology - Volume 68, Issue 4, April 2018, Pages 864-866

Ana da Silva Filipe, Vattipally Sreenu, Joseph Hughes, Elihu Aranday-Cortes, William L. Irving, Graham R. Foster, Kosh Agarwal, William Rosenberg, Douglas Macdonald, Paul Richardson, Mark A. Aldersley, Martin Wiselka, Andrew Ustianowski, John McLauchlan,